EAM
ICPT

EverPoint Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

EverPoint Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-100,000
Closed -$14.3M – 525
2016
Q2 		$14.3M Buy
+100,000
New +$14.6M 0.28% 107

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

EverPoint Asset Management's ICPT Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2016: 9,200 shares worth $1M. The stake represents 0.02% of the portfolio and ranks #372 among its holdings. This is a return to the name: EverPoint Asset Management previously reported a position in ICPT as recently as Q3 2014.

EverPoint Asset Management first reported a position in ICPT in Q3 2014 and has held it in 2 quarters since. The position peaked at $4.73M in Q3 2014. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

  • EverPoint Asset Management held 9,200 shares of Intercept Pharmaceuticals, Inc. worth $1M as of Q4 2016.
  • Intercept Pharmaceuticals, Inc. was a new EverPoint Asset Management position in Q4 2016.
  • Intercept Pharmaceuticals, Inc. made up 0.02% of EverPoint Asset Management's portfolio in Q4 2016, its #372 holding.
  • EverPoint Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and has held it in 2 quarters since.
  • EverPoint Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $4.73M in Q3 2014.
  • 159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.